Dorsal striatal phosphodiesterase 10A and compulsive ethanol use
背侧纹状体磷酸二酯酶 10A 和强迫性乙醇使用
基本信息
- 批准号:10329951
- 负责人:
- 金额:$ 39.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-15 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
ABSTRACT
Alcohol use disorder (AUD) is a chronic, relapsing disorder that afflicts 29% of Americans in their lifetime1,2,
is disabling2 and increases mortality3. New drug targets and neurobiological insight for AUD are needed.
Compulsive drinking putatively involves a transition to dorsal (vs. ventral) striatal control over drinking and a
relative underactivity of indirect pathway MSNs (iMSNs) that enable adaptive behavioral selection in contrast to
overactive direct pathway MSNs (dMSNs) that drive drinking behaviors. Compulsive drinking also involves a
shift to dorsal (caudate-putamen) from ventromedial (nucleus accumbens) striatal control of ethanol-related
behavior. Guided by novel preliminary data, this multidisciplinary project tests the overarching hypothesis that
decreasing dorsal striatal phosphodiesterase 10A (PDE10A) type 2 activity in indirect medium spiny neurons
(MSN) reduces compulsive drinking. In 4 Specific Aims, we seek to fill molecular, circuitry, pharmacological,
behavioral and human genetic gaps in our understanding of the role of PDE10A isoforms in activation of
distinct striatal MSN pathways and compulsive drinking. Aim 1 seeks to identify translatable PDE10A
inhibitors that reduce compulsive-like ethanol self-administration, with consideration of enzyme off-rate,
lipophilic efficiency and neuroactivational effects on distinct MSN circuits. Aim 2 will intersect Adora2a-Cre
rats with expression of a floxed, validiated PDE10A shRNA to knockdown dorsal iMSN PDE10A in order to
determine this the role of caudate-putamen PDE10A in iMSNs in escalated and aversion-resistant self-
administration. Aim 3 seeks to determine the causal role of the striatal-restricted, membrane-associated
PDE10A2 isoform in compulsive-like ethanol intake. Finally, Aim 4 seeks PDE10A gene variants that
associate with problematic alcohol use as well as their functional, expression, and psychiatric genetic
correlates. The collective work of our assembled, multidisciplinary collaborative team will shed light on the
neurobiological and genetic role of PDE10A isoforms in distinct striatal circuits and compulsive drinking
behaviors as well as the potential impact of novel translatable PDE10A inhibitors to treat AUD.
抽象的
酒精使用障碍(AUD)是一种慢性复发障碍,在其一生中遭受29%的美国人的痛苦1,2,
是禁用2并增加死亡率3。需要新的药物靶标和神经生物学见解。
强迫性饮酒预定涉及向背侧(与腹侧)纹状体控制的过渡和
间接途径MSN(IMSN)的相对不足,与适应性行为选择相比
驱动饮酒行为的过度活动直接通路MSN(DMSN)。强迫性饮酒也涉及
从乙醇相关的腹侧(伏隔核)纹状体对照转向背侧(尾状抗耐药型)
行为。在新的初步数据的指导下,这个多学科项目检验了总体假设
间接培养基神经元中降低背纹状体磷酸二酯酶10a(PDE10A)2型活性
(MSN)减少强迫性饮酒。在4个特定目标中,我们寻求填充分子,电路,药理,
行为和人类遗传差距在我们对PDE10A同工型在激活中的作用的理解中
独特的纹状体MSN途径和强迫性饮酒。 AIM 1试图识别可翻译的PDE10A
减少强迫性乙醇自我给药的抑制剂,考虑到酶离速率,
亲脂性效率和神经激活对不同MSN电路的影响。 AIM 2将与Adora2a-cre相交
大鼠表达了flox的,受过验证的PDE10A shRNA以敲除背IMSN PDE10A
确定这一点在升级和抗厌恶的自我中,尾状毒剂pde10a在IMSN中的作用
行政。 AIM 3旨在确定纹状体限制的膜相关的因果作用
强迫性乙醇摄入中的PDE10A2同工型。最后,AIM 4寻求PDE10A基因变体
与有问题的酒精使用以及它们的功能,表达和精神遗传
相关。我们组装的多学科合作团队的集体工作将阐明
PDE10A同工型在不同的纹状体回路和强迫性饮酒中的神经生物学和遗传作用
行为以及新型可翻译PDE10A抑制剂治疗AUD的潜在影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
ERIC P ZORRILLA的其他基金
PPARdelta receptors and alcohol use phenotypes
PPARδ 受体和饮酒表型
- 批准号:1068234810682348
- 财政年份:2023
- 资助金额:$ 39.94万$ 39.94万
- 项目类别:
TRAPping loss of control in binge eating
导致暴饮暴食失控
- 批准号:1021901910219019
- 财政年份:2021
- 资助金额:$ 39.94万$ 39.94万
- 项目类别:
TRAPping loss of control in binge eating
导致暴饮暴食失控
- 批准号:1039763710397637
- 财政年份:2021
- 资助金额:$ 39.94万$ 39.94万
- 项目类别:
Dorsal striatal phosphodiesterase 10A and compulsive ethanol use
背侧纹状体磷酸二酯酶 10A 和强迫性乙醇使用
- 批准号:1054402110544021
- 财政年份:2021
- 资助金额:$ 39.94万$ 39.94万
- 项目类别:
Dorsal striatal phosphodiesterase 10A and compulsive ethanol use
背侧纹状体磷酸二酯酶 10A 和强迫性乙醇使用
- 批准号:1066089210660892
- 财政年份:2021
- 资助金额:$ 39.94万$ 39.94万
- 项目类别:
Extrahypothalamic PPARs and compulsive food intake
下丘脑外 PPAR 和强迫性食物摄入
- 批准号:97465439746543
- 财政年份:2020
- 资助金额:$ 39.94万$ 39.94万
- 项目类别:
Urocortins Brain CRF2 Receptors and Energy Balance
尿皮质素大脑 CRF2 受体和能量平衡
- 批准号:80070288007028
- 财政年份:2010
- 资助金额:$ 39.94万$ 39.94万
- 项目类别:
Urocortins Brain CRF2 Receptors and Energy Balance
尿皮质素大脑 CRF2 受体和能量平衡
- 批准号:78920177892017
- 财政年份:2009
- 资助金额:$ 39.94万$ 39.94万
- 项目类别:
Galanin Control of Food Intake: Molecular, Neuroanatomical and Behavioral Bases
甘丙肽控制食物摄入:分子、神经解剖学和行为基础
- 批准号:78498887849888
- 财政年份:2009
- 资助金额:$ 39.94万$ 39.94万
- 项目类别:
相似国自然基金
自然场景下基于自监督的精准视频情感识别研究
- 批准号:62362003
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
多粒度跨模态信息驱动融合的意图理解及其情感机器人场景应用研究
- 批准号:62373334
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
乳腺癌患者社交网络文本情感自动识别与决策的精准干预系统研制及实证研究
- 批准号:72304131
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
依赖转录因子CTCF的功能性SNP在双相情感障碍发病中的机制研究
- 批准号:82301711
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
双相情感障碍的发病机制研究
- 批准号:32371008
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Regulation of alcohol-induced social disturbances by lateral habenula serotonin receptors
外侧缰核血清素受体调节酒精引起的社交障碍
- 批准号:1066429110664291
- 财政年份:2023
- 资助金额:$ 39.94万$ 39.94万
- 项目类别:
TRAPping loss of control in binge eating
导致暴饮暴食失控
- 批准号:1021901910219019
- 财政年份:2021
- 资助金额:$ 39.94万$ 39.94万
- 项目类别:
TRAPping loss of control in binge eating
导致暴饮暴食失控
- 批准号:1039763710397637
- 财政年份:2021
- 资助金额:$ 39.94万$ 39.94万
- 项目类别:
Dorsal striatal phosphodiesterase 10A and compulsive ethanol use
背侧纹状体磷酸二酯酶 10A 和强迫性乙醇使用
- 批准号:1054402110544021
- 财政年份:2021
- 资助金额:$ 39.94万$ 39.94万
- 项目类别:
Investigating chromatin-based mechanisms of astrocyte pathology during inflammation response and stress-induced behaviors
研究炎症反应和应激诱导行为期间基于染色质的星形胶质细胞病理学机制
- 批准号:1024617710246177
- 财政年份:2020
- 资助金额:$ 39.94万$ 39.94万
- 项目类别: